Mapping the global influence of published research on industry and innovation

Science quality and the value of inventions

“…Given that this is less than 2% of the total, for simplicity, we disregard these links in our analysis.Our final sample contains 952,932 DOCDB patent families with at least one grant publication and at least one matched SNPL reference at any of the patent offices considered here.This compares well with previous datasets, and in general, constitute a larger number of observations than previously identified in existing studies Ahmadpoor and Jones (2017). use patent data exclusively at the USPTO between 1976 and 2015 where 759,000 patents were found to be directly linked to at least one scientific publication in WoS via an NPL reference Jefferson et al (2018). starts with 11.8 million scientific publications published between 1980 and 2015, of which roughly 1.2 million are cited in 690,000 patent families (1.1 million patents) Marx and Fuegi (2019).…”

Using the Lens database for staff publications

“…It is worth noting that all mapped patent sequences relating to the human genome are available here. The In4M tool uses citationbased metrics to map the influence of research on industry and innovation, potentially facilitating collaborations and funding partnerships [12]. It currently covers universities and large research institutes only but will be significantly expanded in 2020 [13].…”

Recent Contributions of Agricultural Economics Research in the Field of Sustainable Development

“…Hence, the economic evaluation of the innovative products can provide evidence of the real economic feasibility of new solutions, and their concrete contribution to a more sustainable agriculture. This specific innovation sector is suited to be studied using patent data [52][53][54][55][56][57] on agbiotech patents granted internationally, by disentangling the role of private, public, and private-public collaborations in producing agbiotech innovations. Frisio et al [58] evaluated the agbiotech patent landscape for genetically modified (GM) innovations, showing that the private sector played a major role in the overall production of agbiotech patents, while the public sector is specialized in fundamental research fields.…”